Aquestive Therapeutics Inc (AQST)
EBITDA Margin
-136.68%
Quarterly · Period ending:
AQST EBITDA Margin
Latest reported-136.68%period ending
Latest reported-136.68%period ending
AQST Quarterly EBITDA Margin (10.40% → -136.68%)
Quarterly ebitda margin
High-resolution chart · PNG
AQST ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -136.6814% | |
| -27.7447% | |
| -210.9643% | |
| -86.156% | |
| -91.2926% | |
| -212.305% | |
| -107.0026% | |
| -52.8135% | |
| 8.2342% | |
| -69.8664% | |
| -32.6215% | |
| -4.6147% | |
| -28.6308% | |
| 88.7372% | |
| -95.9652% | |
| -71.9881% | |
| -90.9386% | |
| -73.4393% | |
| -222.2874% | |
| -54.4291% | |
| -35.2036% | |
| -69.8615% | |
| -200.9232% | |
| -158.8378% | |
| 5.5825% | |
| -146.8568% | |
| -55.4845% | |
| -120.9212% | |
| -159.7179% | |
| -95.0486% | |
| -67.059% | |
| -93.156% | |
| -242.5976% | |
| 29.8108% | |
| -58.2452% | |
| 42.0283% | |
| -26.9162% | |
| 10.3979% |